Septerna, Inc. (SEPN) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Elizabeth Bhatt

President and COO

—

$149.64K (2) scheduled

−$149.64K

174,209

0.3732%

$6.55M

0.0%

Third Rock Ventures V, L.P. entity

10% owner

—

6,068,391

13.00%

$228.26M

+2.5%

Third Rock Ventures VI, L.P. entity

10% owner

—

4,211,659

9.02%

$158.42M

+33.6%

Jeffrey Finer

Chief Executive Officer

—

826,907

1.77%

$31.10M

+9.5%

Ra Capital Management, L.p. entity

Director

—

725,443

1.55%

$27.29M

−67.3%

Alan Ezekowitz

Director

—

117,420

0.2516%

$4.42M

+574.1%

Daniel D. Long

SVP, Drug Discovery

—

96,412

0.2066%

$3.63M

−3.5%

Gil M Labrucherie

Chief Financial Officer

—

40,000

0.0857%

$1.50M

—

Uwe Klein

SVP, Biological Sciences

—

23,008

0.0493%

$865.43K

—

Samira Shaikhly

Chief People Officer

—

793

0.0017%

$29.83K

0.0%

Septerna, Inc.

What the insiders did Scheduled selling only

By person